Increased Dosage of Runx1/Aml1 Acts as a Positive Modulator of Myeloid Leukemogenesis in BXH2 Mice

Oncogene - United Kingdom
doi 10.1038/sj.onc.1208675
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Paradoxical Enhancement of Leukemogenesis in Acute Myeloid Leukemia With Moderately Attenuated RUNX1 Expressions

Blood advances
Hematology
2017English

A Minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 Contributes to Leukemogenesis in T(8;21) Acute Myeloid Leukemia

International Journal of Cancer
Cancer ResearchOncology
2016English

RUNX1–ETO Upregulates CCND2 to Drive Leukemogenesis

Cancer Discovery
Oncology
2018English

The Anti-Convulsant Stiripentol Acts Directly on the GABAA Receptor as a Positive Allosteric Modulator

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2009English

AML1 (Acute Myeloid Leukemia 1)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2010English

NHR4 Domain Mutations of ETO Are Probably Very Infrequent in AML1–ETO Positive Myeloid Leukemia Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

AML1/RUNX1 Point Mutation Possibly Promotes Leukemic Transformation in Myeloproliferative Neoplasms

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

S-Nitrosoglutathione Acts as a Small Molecule Modulator of Human Fibrin Clot Architecture

PLoS ONE
Multidisciplinary
2012English

Spermine Acts as a Negative Regulator of Macrophage Differentiation in Human Myeloid Leukemia Cells

Cancer Research
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy